• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Development and validation of an immunogenic cell death-related prognostic model, and landscape of the tumor immune microenvironment in glioblastoma.

作者信息

Yang Sha, Deng Mei, Xiong Yunbiao, Xiong Bing, Fu Junwu, Wang Jia, Zhang Jiqin, Han Guoqiang, Liu Jian, Tan Ying

机构信息

Guizhou University Medical College, Guiyang, Guizhou 550025, China.

Department of Neurosurgery, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, China.

出版信息

Genes Dis. 2023 Jun 28;11(3):101001. doi: 10.1016/j.gendis.2023.04.032. eCollection 2024 May.

DOI:10.1016/j.gendis.2023.04.032
PMID:38274376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10806272/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/f56f0b627c81/figs10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/bef51f097075/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/b8991e027313/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/85cf12261beb/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/191e14ec39f9/figs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/c6f886fb86f5/figs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/e94d2c161c6c/figs5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/fa1b74e6047b/figs6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/ca35bb733dbb/figs7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/d7fe5f33ca39/figs8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/85eed794017e/figs9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/f56f0b627c81/figs10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/bef51f097075/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/b8991e027313/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/85cf12261beb/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/191e14ec39f9/figs3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/c6f886fb86f5/figs4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/e94d2c161c6c/figs5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/fa1b74e6047b/figs6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/ca35bb733dbb/figs7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/d7fe5f33ca39/figs8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/85eed794017e/figs9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49a9/10806272/f56f0b627c81/figs10.jpg

相似文献

1
Development and validation of an immunogenic cell death-related prognostic model, and landscape of the tumor immune microenvironment in glioblastoma.胶质母细胞瘤中免疫原性细胞死亡相关预后模型的建立与验证以及肿瘤免疫微环境全景分析
Genes Dis. 2023 Jun 28;11(3):101001. doi: 10.1016/j.gendis.2023.04.032. eCollection 2024 May.
2
Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma.免疫原性细胞死亡相关特征的开发和验证，用于预测葡萄膜黑色素瘤的预后和免疫景观。
Front Immunol. 2022 Nov 16;13:1037128. doi: 10.3389/fimmu.2022.1037128. eCollection 2022.
3
Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.系统识别、开发和验证涉及胶质母细胞瘤肿瘤免疫微环境的预后生物标志物。
J Cell Physiol. 2021 Jan;236(1):507-522. doi: 10.1002/jcp.29878. Epub 2020 Jun 22.
4
Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment.急性髓系白血病中免疫原性细胞死亡的综合特征揭示其与预后及肿瘤免疫微环境的关联
BMC Med Genomics. 2024 Apr 26;17(1):107. doi: 10.1186/s12920-024-01876-w.
5
Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma.基于免疫原性细胞死亡相关基因的模型的开发与验证，用于预测膀胱尿路上皮癌的预后和免疫反应。
Front Oncol. 2023 Nov 10;13:1291720. doi: 10.3389/fonc.2023.1291720. eCollection 2023.
6
Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.一种新型免疫原性细胞死亡相关特征的开发与验证，用于预测三阴性乳腺癌的预后和免疫浸润。
Cancer Rep (Hoboken). 2024 Mar;7(3):e2007. doi: 10.1002/cnr2.2007.
7
Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM.免疫原性细胞死亡相关风险模型用于描绘 GBM 患者的铁死亡途径并预测免疫治疗反应。
Front Immunol. 2022 Sep 26;13:992855. doi: 10.3389/fimmu.2022.992855. eCollection 2022.
8
Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.透明质酸缀合物联合免疫原性细胞死亡诱导剂和 CpG 用于胶质母细胞瘤局部化疗免疫治疗可引发免疫反应并诱导长期生存。
Biomaterials. 2023 Mar;294:122006. doi: 10.1016/j.biomaterials.2023.122006. Epub 2023 Jan 21.
9
Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.与免疫原性细胞死亡相关的分类可预测低级别胶质瘤的预后、免疫微环境特征和对免疫治疗的反应。
Front Immunol. 2023 Apr 19;14:1102094. doi: 10.3389/fimmu.2023.1102094. eCollection 2023.
10
Identifying an immunogenic cell death-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma.鉴定与免疫原性细胞死亡相关的基因特征有助于预测肺腺癌的预后、免疫治疗疗效和肿瘤微环境。
Aging (Albany NY). 2024 Apr 3;16(7):6290-6313. doi: 10.18632/aging.205705.

本文引用的文献

1
Glioblastoma: Changing concepts in the WHO CNS5 classification.胶质母细胞瘤：在世界卫生组织 CNS5 分类中的变化概念。
Indian J Pathol Microbiol. 2022 May;65(Supplement):S24-S32. doi: 10.4103/ijpm.ijpm_1109_21.
2
Targeting immunogenic cell death in cancer.针对癌症的免疫原性细胞死亡。
Mol Oncol. 2020 Dec;14(12):2994-3006. doi: 10.1002/1878-0261.12851. Epub 2020 Dec 1.
3
Immunogenic cell death in cancer therapy: Present and emerging inducers.癌症治疗中的免疫原性细胞死亡：现有和新兴的诱导剂。
J Cell Mol Med. 2019 Aug;23(8):4854-4865. doi: 10.1111/jcmm.14356. Epub 2019 Jun 18.
4
Current state of immunotherapy for glioblastoma.胶质母细胞瘤的免疫治疗现状。
Nat Rev Clin Oncol. 2018 Jul;15(7):422-442. doi: 10.1038/s41571-018-0003-5.
5
The Microenvironmental Landscape of Brain Tumors.脑肿瘤的微环境格局
Cancer Cell. 2017 Mar 13;31(3):326-341. doi: 10.1016/j.ccell.2017.02.009.